OrliFord pills are manufactured by Banford.
OrliFord is recommended to control obesity in patients with the BMI greater or equal to 30 kg/m² (or with BMI greater or equal to 28 kg/m² with associated risk factors).
The active ingredient of OrliFord is Orlistat – a gastrointestinal lipase inhibitor that acts by inhibiting the absorption of fats and eliminating them from the body with the stools.
Losing weight with OrliFord and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life.
Taking OrliFord also keeps patients from gaining weight back after prior weight loss.
OrliFord is available in:
- 120mg Standard Dosage
Take one pill of OrliFord orally 3 times a day during the main meal or up to 1 hour after the meal.
The diet of the patient should include three main meals, containing the daily dose of fat, carbohydrate, and protein.
The daily intake of fat should be no more than 30% of your total daily caloric intake (e.g., eating 1200 calories per day, no more than 360 of those calories should be in the form of fat).
The dose of OrliFord should be omitted if a meal is missed or does not contain fat.
Treatment with OrliFord should not continue for more than 6 months and should be stopped after 12 weeks if patient has been unable to lose at least 5 % of the body weight.
If you lose enough weight for your BMI to fall below 28 kg/m²,OrliFord can no longer be supplied.
Missing a dose
If you miss a dose you should take it as soon as you remember about your missing. If it is the time for the next dose you should continue your regular dosing schedule. Do not exceed the doctor’s recommended dose.
If an overdose occurs and you are not feeling well, you should seek emergency medical attention or contact your healthcare provider immediately.
Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F) and away from excess moisture and heat. Throw away any unused medicine after the expiration date. Keep out of the reach of children.